Medicinal product name Komboglyze
Pharmaceutical form Film-coated tablet
Strength 2.5 mg/850 mg 
Information from the MAH on shortages Not notified
Legal status Rx Prescription (Pr.)
Summary of product characteristics, package leaflet and labeling text  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
ATC code A10BD10 Drugs used in diabetes

Important notice

Additional information regarding the use for persons aged 75+

If used as "DRUGS USED IN DIABETES"
SubstanceClassComment
SaxagliptinumCSuitable for older adults, with specific precautions. Reduce the dose already in moderately severe renal impairment. Do not use in hepatic impairment.
Metformini hydrochloridum No data on active substance.

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N60: 60 × 1
(2,5 mg/850 mg)
Al/Al unit-dose blister    EU/1/11/731/006  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website

Registration information

Marketing authorisation No. EU/1/11/731/006
Date of authorisation Nov 24, 2011
Marketing authorisation holder, country AstraZeneca AB, Sweden